肝细胞-话题@MedSci

#肝细胞#

513篇内容 | 6440人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1863616, encodeId=3c461863616c3, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Front Oncol：仑伐替尼（lenvatinib）对比索拉非尼（Sorafenib）治疗晚期肝细胞癌的疗效：倾向评分匹配（PSM）分析, objectType=article, longId=219316, objectId=14432193166f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14432193166f, replyNumber=0, likeNumber=94, createdTime=2022-06-10, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14432193166f, moduleTitle=Front Oncol：仑伐替尼（lenvatinib）对比索拉非尼（Sorafenib）治疗晚期肝细胞癌的疗效：倾向评分匹配（PSM）分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14432193166f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863574, encodeId=33e618635e43d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=共识解读：免疫联合靶向方案为我国晚期肝细胞癌转化治疗开辟新方向！, objectType=article, longId=212517, objectId=e01721251ecb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e01721251ecb, replyNumber=0, likeNumber=90, createdTime=2021-08-10, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e01721251ecb, moduleTitle=共识解读：免疫联合靶向方案为我国晚期肝细胞癌转化治疗开辟新方向！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e01721251ecb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863580, encodeId=eef71863580c0, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Liver Cancer：卡博替尼（Cabozantinib）治疗不可手术切除肝细胞癌的疗效和安全性：真实世界研究结果, objectType=article, longId=213115, objectId=9d6a213115e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d6a213115e4, replyNumber=0, likeNumber=81, createdTime=2021-09-03, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d6a213115e4, moduleTitle=Liver Cancer：卡博替尼（Cabozantinib）治疗不可手术切除肝细胞癌的疗效和安全性：真实世界研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d6a213115e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863595, encodeId=4a53186359517, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Nat Cancer：新辅助治疗药物卡博替尼和纳武单抗治疗局部晚期肝细胞癌, objectType=article, longId=215171, objectId=df392151e1d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df392151e1d8, replyNumber=0, likeNumber=102, createdTime=2022-06-16, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df392151e1d8, moduleTitle=Nat Cancer：新辅助治疗药物卡博替尼和纳武单抗治疗局部晚期肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df392151e1d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863539, encodeId=b28c18635397b, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=GUT：HBV整合促进肝细胞癌局部及远距离致癌驱动因子的改变, objectType=article, longId=207042, objectId=aaa020e042e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaa020e042e3, replyNumber=0, likeNumber=102, createdTime=2021-06-16, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaa020e042e3, moduleTitle=GUT：HBV整合促进肝细胞癌局部及远距离致癌驱动因子的改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaa020e042e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863617, encodeId=3418186361e5f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响, objectType=article, longId=219336, objectId=97b7219336b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97b7219336b4, replyNumber=0, likeNumber=90, createdTime=2022-04-02, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97b7219336b4, moduleTitle=Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97b7219336b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863566, encodeId=39a1186356665, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Dig Dis Sci：中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关, objectType=article, longId=211890, objectId=c50f211890e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c50f211890e4, replyNumber=0, likeNumber=114, createdTime=2022-05-02, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c50f211890e4, moduleTitle=Dig Dis Sci：中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c50f211890e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863540, encodeId=efac1863540b5, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Nature BME:一种未检测到RNA和DNA脱靶突变的肝细胞内胞苷碱基编辑方法, objectType=article, longId=207212, objectId=f0d420e212b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0d420e212b2, replyNumber=0, likeNumber=88, createdTime=2021-11-27, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0d420e212b2, moduleTitle=Nature BME:一种未检测到RNA和DNA脱靶突变的肝细胞内胞苷碱基编辑方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0d420e212b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863611, encodeId=cf47186361107, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Br J Cancer：晚期肝细胞癌患者诊断性活检的可行性分析, objectType=article, longId=218510, objectId=91142185104b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91142185104b, replyNumber=0, likeNumber=81, createdTime=2022-02-07, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91142185104b, moduleTitle=Br J Cancer：晚期肝细胞癌患者诊断性活检的可行性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91142185104b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863537, encodeId=a233186353e47, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Nat Commun：肝细胞多倍体化诱导肝细胞癌癌前病变的发生, objectType=article, longId=206848, objectId=152c206848c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=152c206848c1, replyNumber=0, likeNumber=133, createdTime=2021-04-13, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=152c206848c1, moduleTitle=Nat Commun：肝细胞多倍体化诱导肝细胞癌癌前病变的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=152c206848c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863550, encodeId=cd4b186355067, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Dig Dis Sci: 甲胎蛋白水平是肝细胞癌患者根治性切除的重要指标, objectType=article, longId=209598, objectId=236c2095982f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=236c2095982f, replyNumber=0, likeNumber=84, createdTime=2022-01-11, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=236c2095982f, moduleTitle=Dig Dis Sci: 甲胎蛋白水平是肝细胞癌患者根治性切除的重要指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=236c2095982f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863588, encodeId=23121863588eb, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, objectType=article, longId=214297, objectId=744721429ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744721429ee4, replyNumber=0, likeNumber=173, createdTime=2022-06-25, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744721429ee4, moduleTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744721429ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863582, encodeId=44cb186358290, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=JAMA Netw Open：肝细胞癌超声筛查：间隔少于 6 个月更佳, objectType=article, longId=213329, objectId=17e521332904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17e521332904, replyNumber=0, likeNumber=104, createdTime=2022-05-07, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17e521332904, moduleTitle=JAMA Netw Open：肝细胞癌超声筛查：间隔少于 6 个月更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17e521332904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863548, encodeId=4966186354852, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=“特瑞普利单抗+贝伐珠单抗”一线治疗晚期肝细胞癌临床研究新近进展发布, objectType=article, longId=208886, objectId=8dd6208886d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dd6208886d9, replyNumber=0, likeNumber=0, createdTime=2021-07-05, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dd6208886d9, moduleTitle=“特瑞普利单抗+贝伐珠单抗”一线治疗晚期肝细胞癌临床研究新近进展发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dd6208886d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863587, encodeId=e662186358e3d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Clin Cancer Res：预测仑伐替尼（Lenvatinib）在不可切除肝细胞癌中生存获益的药效学生物标志物:来自III期REFLECT研究, objectType=article, longId=214268, objectId=9fbc2142681c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fbc2142681c, replyNumber=0, likeNumber=124, createdTime=2021-11-20, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fbc2142681c, moduleTitle=Clin Cancer Res：预测仑伐替尼（Lenvatinib）在不可切除肝细胞癌中生存获益的药效学生物标志物:来自III期REFLECT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fbc2142681c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863541, encodeId=869b186354122, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Eur Radiol:肝特异性MR对比剂除了能鉴别肝细胞肝癌还能做什么？, objectType=article, longId=207534, objectId=64ad20e53415, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64ad20e53415, replyNumber=0, likeNumber=82, createdTime=2021-04-18, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64ad20e53415, moduleTitle=Eur Radiol:肝特异性MR对比剂除了能鉴别肝细胞肝癌还能做什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ad20e53415)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863586, encodeId=476218635866e, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Liver Cancer：雷莫芦单抗（Ramucirumab）治疗甲胎蛋白升高的中期肝细胞癌（HCC）患者的疗效:来自两项3期研究(REACH和REACH-2)的汇总结果, objectType=article, longId=214189, objectId=ceaa214189f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceaa214189f7, replyNumber=0, likeNumber=98, createdTime=2021-09-27, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceaa214189f7, moduleTitle=Liver Cancer：雷莫芦单抗（Ramucirumab）治疗甲胎蛋白升高的中期肝细胞癌（HCC）患者的疗效:来自两项3期研究(REACH和REACH-2)的汇总结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ceaa214189f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863551, encodeId=8c74186355149, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=World J Gastroenterology：化学栓塞术对肝细胞癌患者短期和长期预后的影响, objectType=article, longId=209642, objectId=0bbc2096428f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bbc2096428f, replyNumber=0, likeNumber=95, createdTime=2021-09-06, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bbc2096428f, moduleTitle=World J Gastroenterology：化学栓塞术对肝细胞癌患者短期和长期预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bbc2096428f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863555, encodeId=229418635558a, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Clin Gastroenterol H：非酒精性脂肪肝患者肝细胞癌发病率分析, objectType=article, longId=210958, objectId=23f22109581e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23f22109581e, replyNumber=0, likeNumber=86, createdTime=2021-10-23, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23f22109581e, moduleTitle=Clin Gastroenterol H：非酒精性脂肪肝患者肝细胞癌发病率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23f22109581e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863589, encodeId=c57818635893f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Liver Cancer：不可切除肝细胞癌患者基线肝功能和预后的关系：来自3期临床研究REFLECT患者的分析结果, objectType=article, longId=214329, objectId=ec54214329a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec54214329a3, replyNumber=0, likeNumber=74, createdTime=2021-12-02, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec54214329a3, moduleTitle=Liver Cancer：不可切除肝细胞癌患者基线肝功能和预后的关系：来自3期临床研究REFLECT患者的分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec54214329a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝细胞

2020-05-29

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Front Oncol：仑伐替尼（lenvatinib）对比索拉非尼（Sorafenib）治疗晚期肝细胞癌的疗效：倾向评分匹配（PSM）分析

2022-06-10

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

共识解读：免疫联合靶向方案为我国晚期肝细胞癌转化治疗开辟新方向！

2021-08-10

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Liver Cancer：卡博替尼（Cabozantinib）治疗不可手术切除肝细胞癌的疗效和安全性：真实世界研究结果

2021-09-03

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Nat Cancer：新辅助治疗药物卡博替尼和纳武单抗治疗局部晚期肝细胞癌

2022-06-16

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

GUT：HBV整合促进肝细胞癌局部及远距离致癌驱动因子的改变

2021-06-16

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响

2022-04-02

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Dig Dis Sci：中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关

2022-05-02

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Nature BME:一种未检测到RNA和DNA脱靶突变的肝细胞内胞苷碱基编辑方法

2021-11-27

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Br J Cancer：晚期肝细胞癌患者诊断性活检的可行性分析

2022-02-07

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Nat Commun：肝细胞多倍体化诱导肝细胞癌癌前病变的发生

2021-04-13

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Dig Dis Sci: 甲胎蛋白水平是肝细胞癌患者根治性切除的重要指标

2022-01-11

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系

2022-06-25

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

JAMA Netw Open：肝细胞癌超声筛查：间隔少于 6 个月更佳

2022-05-07

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

“特瑞普利单抗+贝伐珠单抗”一线治疗晚期肝细胞癌临床研究新近进展发布

2021-07-05

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Clin Cancer Res：预测仑伐替尼（Lenvatinib）在不可切除肝细胞癌中生存获益的药效学生物标志物:来自III期REFLECT研究

2021-11-20

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Eur Radiol:肝特异性MR对比剂除了能鉴别肝细胞肝癌还能做什么？

2021-04-18

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Liver Cancer：雷莫芦单抗（Ramucirumab）治疗甲胎蛋白升高的中期肝细胞癌（HCC）患者的疗效:来自两项3期研究(REACH和REACH-2)的汇总结果

2021-09-27

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

World J Gastroenterology：化学栓塞术对肝细胞癌患者短期和长期预后的影响

2021-09-06

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Clin Gastroenterol H：非酒精性脂肪肝患者肝细胞癌发病率分析

2021-10-23

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Liver Cancer：不可切除肝细胞癌患者基线肝功能和预后的关系：来自3期临床研究REFLECT患者的分析结果

2021-12-02

科室
- - 订阅+
  - 更多科室
工具
服务